Martin Kohlhäeufl

1.5k total citations
13 papers, 479 citations indexed

About

Martin Kohlhäeufl is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Martin Kohlhäeufl has authored 13 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Martin Kohlhäeufl's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Martin Kohlhäeufl is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Lung Cancer Research Studies (5 papers). Martin Kohlhäeufl collaborates with scholars based in Germany, Spain and Italy. Martin Kohlhäeufl's co-authors include R. Siekmeier, Peter Brand, G. Scheuch, Everett E. Vokes, Laura Q.M. Chow, David R. Spigel, Scott Gettinger, Esther Holgado, Julie R. Brahmer and Hossein Borghaei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Advanced Drug Delivery Reviews.

In The Last Decade

Martin Kohlhäeufl

13 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Kohlhäeufl Germany 9 363 236 52 43 42 13 479
Takashi Aiko Japan 9 329 0.9× 123 0.5× 22 0.4× 26 0.6× 45 1.1× 24 528
Mika Kitagawa Japan 11 191 0.5× 96 0.4× 11 0.2× 18 0.4× 128 3.0× 29 410
Takayuki Takimoto Japan 10 139 0.4× 101 0.4× 36 0.7× 26 0.6× 63 1.5× 51 289
Tatsunori Kiriu Japan 13 186 0.5× 199 0.8× 15 0.3× 54 1.3× 119 2.8× 26 460
Masayoshi Kuwabara Japan 9 154 0.4× 79 0.3× 62 1.2× 4 0.1× 29 0.7× 50 313
F. Rolland France 11 164 0.5× 230 1.0× 10 0.2× 15 0.3× 99 2.4× 29 457
Chao Lin China 15 160 0.4× 256 1.1× 21 0.4× 65 1.5× 163 3.9× 47 592
Adolfo Baloira Spain 12 343 0.9× 31 0.1× 116 2.2× 12 0.3× 102 2.4× 35 463
Takashi Ogura Japan 10 97 0.3× 189 0.8× 19 0.4× 16 0.4× 38 0.9× 38 464

Countries citing papers authored by Martin Kohlhäeufl

Since Specialization
Citations

This map shows the geographic impact of Martin Kohlhäeufl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Kohlhäeufl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Kohlhäeufl more than expected).

Fields of papers citing papers by Martin Kohlhäeufl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Kohlhäeufl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Kohlhäeufl. The network helps show where Martin Kohlhäeufl may publish in the future.

Co-authorship network of co-authors of Martin Kohlhäeufl

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Kohlhäeufl. A scholar is included among the top collaborators of Martin Kohlhäeufl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Kohlhäeufl. Martin Kohlhäeufl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schuette, Wolfgang, Claus-Peter Schneider, Walburga Engel-Riedel, et al.. (2017). 65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer. SHILAP Revista de lepidopterología. Volume 8. 217–229. 8 indexed citations
2.
Bonella, Francesco, Michael Kreuter, Lars Hagmeyer, et al.. (2016). Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis. Respiration. 92(2). 98–106. 58 indexed citations
3.
Goldman, Jonathan W., Lucio Crinò, Everett E. Vokes, et al.. (2016). Nivolumab (nivo) in patients (pts) with advanced (adv) NSCLC and central nervous system (CNS) metastases (mets).. Journal of Clinical Oncology. 34(15_suppl). 9038–9038. 27 indexed citations
4.
5.
Paz‐Ares, Luis, Leora Horn, Hossein Borghaei, et al.. (2015). Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 33(15_suppl). LBA109–LBA109. 28 indexed citations
6.
Paz‐Ares, Luis, Leora Horn, Hossein Borghaei, et al.. (2015). Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 33(18_suppl). LBA109–LBA109. 121 indexed citations
7.
Kohlhäeufl, Martin, et al.. (2014). Pirfenidone in idiopathic pulmonary fibrosis - description of a German cohort. European Respiratory Journal. 44(Suppl 58). P3749–P3749. 1 indexed citations
8.
Kohlhäeufl, Martin, et al.. (2013). Treatment of Severe Advanced Emphysema With Volume Reduction Using Lung Sealant. Journal of Bronchology & Interventional Pulmonology. 20(1). 58–62. 2 indexed citations
9.
10.
Dansin, Éric, Saverio Cinieri, Pilar Garrido, et al.. (2012). MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC. Lung Cancer. 76(3). 373–379. 25 indexed citations
11.
Kimmich, Martin, et al.. (2011). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: 7-year follow-up of a rare clinicopathologic syndrome. Journal of Cancer Research and Clinical Oncology. 137(10). 1495–1498. 15 indexed citations
12.
13.
Scheuch, G., Martin Kohlhäeufl, Peter Brand, & R. Siekmeier. (2006). Clinical perspectives on pulmonary systemic and macromolecular delivery. Advanced Drug Delivery Reviews. 58(9-10). 996–1008. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Aiko Breakdown of academic impact, for papers by Mika Kitagawa Breakdown of academic impact, for papers by Takayuki Takimoto Breakdown of academic impact, for papers by Tatsunori Kiriu Breakdown of academic impact, for papers by Masayoshi Kuwabara Breakdown of academic impact, for papers by F. Rolland Breakdown of academic impact, for papers by Chao Lin Breakdown of academic impact, for papers by Adolfo Baloira Breakdown of academic impact, for papers by Takashi Ogura
Rankless by CCL
2026